(1 - 16 von 38
)
Evotec OAI und MediGene identifizieren neue ...Evotec
www.evotec.com
Christine Bohner, Public Relations Michael Nettersheim, Investor Relations OBEN. Friday, April 12th Christine Bohner, Public Relations Michael Nettersheim, Investor Relations OBEN. Friday, April 12th
Evotec OAI and MediGene have Identified New Active ...Evotec Website
www.evotec.com
Christine Bohner, Public Relations Tel: ++ Michael Nettersheim, Investor Relations Tel: ++ Evotec OAI AG Email ... Christine Bohner, Public Relations Tel: ++ Michael Nettersheim, Investor Relations Tel: ++ Evotec OAI AG Email ...
MediGene nutzt Evotec OAIs führende Technologie bei der ...Evotec Website
www.evotec.com
Christine Bohner, Public Relations Tel: ++ Michael Nettersheim, Investor Relations Tel: ++ Our Solutions · Our ... Christine Bohner, Public Relations Tel: ++ Michael Nettersheim, Investor Relations Tel: ++ Our Solutions · Our ...
Business News: The Denver Post
extras.denverpost.com
The German biotechnology company will seek European approval for the product at the beginning of 2002, said MediGene spokeswoman Christine Bohner in an interview.
sortiert nach Relevanz / Datum